These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 13658270)
1. [Preliminary clinical investigations on a new indandione type anticoagulant: anisindione]. BALLERINI G; LA PAGLIA S Prog Med (Napoli); 1959 Jan; 15(2):46-8. PubMed ID: 13658270 [No Abstract] [Full Text] [Related]
2. [RESEARCH ON THE ANTICOAGULANT ACTION OF AN INDANDIONE DERIVATIVE (ANISINDIONE) WITH PROLONGED ACTION]. GIBELLI A; DELUTTEROTTI A Rass Int Clin Ter; 1964 Jan; 44():1-8. PubMed ID: 14126507 [No Abstract] [Full Text] [Related]
3. Evaluation of anticoagulant therapy with anisindione (miradon). CONNELL WF; MAYER GA Can Med Assoc J; 1959 May; 80(10):785-90. PubMed ID: 13652026 [No Abstract] [Full Text] [Related]
4. Anisindione: a new anticoagulant with unusual properties. LANGE K; PERCHUK E; MAHL M; ENZINGER J; MOURATOFF G Am Heart J; 1958 Jan; 55(1):73-9. PubMed ID: 13520554 [No Abstract] [Full Text] [Related]
6. [Clinical trial of a new anticoagulant: 2-(4-bromophenyl)-1,3-indandione]. BRUNE J; VERNEYRE H; DELAHAYE JP Lyon Med; 1962 Mar; 94():565-72. PubMed ID: 13873987 [No Abstract] [Full Text] [Related]
7. Anticoagulation with anisindione in patients who are intolerant of warfarin. Grosset AB; Allen JE; Rodgers GM Am J Hematol; 1994 Jun; 46(2):138-40. PubMed ID: 8172181 [TBL] [Abstract][Full Text] [Related]
8. [Clinical studies on the coagulation-inhibiting activity of a new anticoagulant of the indandione series]. STROBEL E Arzneimittelforschung; 1962 Jul; 12():718-20. PubMed ID: 13917816 [No Abstract] [Full Text] [Related]
9. [Effect of nucleophilic and electrophilic substitutes on the anticoagulant action of various 2-phenyl-1, 3-indandione derivatives]. CAVALLINI G; MILLA E; GRUMMELLI E; RAVENNA F Farmaco Sci; 1955; 10(10):710-32. PubMed ID: 13294151 [No Abstract] [Full Text] [Related]
11. Effect in man of a new indandione anticoagulant. FIELD JB; GOLDFARB MS; WARE AG; GRIFFITH GC Proc Soc Exp Biol Med; 1952 Dec; 81(3):678-81. PubMed ID: 13037763 [No Abstract] [Full Text] [Related]
12. [Clinical evaluation of the anticoagulant, anisindione]. BUZZI A; CARBAJAL B Prensa Med Argent; 1961 Jun; 48():1826-9. PubMed ID: 13875273 [No Abstract] [Full Text] [Related]
13. A preliminary report on the clinical use of a new anticoagulant (miradon). BLAUSTEIN A N Y State J Med; 1958 Mar; 58(5):701-2. PubMed ID: 13517546 [No Abstract] [Full Text] [Related]
14. Anticoagulation with anisindione in a patient with a warfarin-induced skin eruption. Spyropoulos AC; Hayth KA; Jenkins P Pharmacotherapy; 2003 Apr; 23(4):533-6. PubMed ID: 12680483 [TBL] [Abstract][Full Text] [Related]
15. Clinical experience with a new anticoagulant, dipaxin (2-diphenylacetyl-1,3-indandione). PASCALE LR; OLWIN JH Circulation; 1954 Feb; 9(2):230-7. PubMed ID: 13127184 [No Abstract] [Full Text] [Related]
17. [Potentiation of the anticoagulant effect of fluindione by propafenone]. Welsch M; Heitz C; Stephan D; Imbs JL Therapie; 1991; 46(3):254-5. PubMed ID: 1792662 [No Abstract] [Full Text] [Related]
18. Dipaxin: 2-diphenylacetyl-1,3-indandione; clinical evaluation of a new anticoagulant. FIELD JB; GOLDFARB MS; WARE AG; GRIFFITH GC Circulation; 1955 Apr; 11(4):576-83. PubMed ID: 14364732 [No Abstract] [Full Text] [Related]
19. THE ANTICOAGULANT ACTION OF 2,2'-ARYLENE-BIS-INDANDIONE-1,3. GUMINSKA M; ECKSTEIN M; STACHURSKA B Farmaco Sci; 1964 Aug; 19():653-60. PubMed ID: 14180152 [No Abstract] [Full Text] [Related]
20. An evaluation of anisindione, a new and useful oral anticoagulant. Preliminary report. WILLIS PW; ZWEIFLER AJ J Mich State Med Soc; 1962 Nov; 61():1386-7. PubMed ID: 14000965 [No Abstract] [Full Text] [Related] [Next] [New Search]